Metformin is a widely used drug in today's prescriptions by physicians due to its specific
effects in treating and curing type II diabetes. Diabetes is a common disease that may occur …

This systematic review investigated whether the insulin sensitiser metformin has a
geroprotective effect in humans. Pubmed and Embase were searched along with databases …

Previous meta-analyses have shown that the antidiabetic agent metformin is associated with
reduced cancer incidence and mortality. However, this effect has not been consistently …

Aims/Hypothesis Diabetes treatments were related with either an increased or reduced risk
of cancer. There is ongoing debate about a potential protective action of metformin. To …

PURPOSE: To assess the effect of metformin intake on cancer incidence and mortality.
METHODS: Original articles in English published until June 15, 2012 were searched for in …

Metformin, one of most widely prescribed oral hypoglycemic agents, has recently received
increased attention because of its potential antitumorigenic effects that are thought to be …

Melanoma is the most lethal skin cancer characterized by its high metastatic potential. It is
urgent to find novel therapy strategies to overcome this feature. Metformin has been …

This guideline refers primarily to type 2 diabetes in the older person. There is limited
information on the management of type 1 diabetes in the elderly, but this is included …

Increasing evidence suggests a complex relationship between obesity, diabetes and cancer.
Here we review the evidence for the association between obesity and diabetes and a wide …

Aims Recent epidemiological studies indicated that use of metformin might decrease the risk
of various cancers among patients with type 2 diabetes mellitus (T2DM). However, its …